H5N1 clade 2.3.4.4b avian influenza viruses replicate in differentiated bovine airway epithelial cells cultured at air-liquid interface
A single mutation in dairy cow-associated H5N1 viruses increases receptor binding breadth
Clade 2.3.4.4b H5N1 is causing an unprecedented outbreak in dairy cows in the United States.
Scientific Papers
News
Podcasts
Are We Prepared for Bird Flu? — ITT Episode 32
A new strain of H5N1 influenza is spreading in dairy cows in the United States.
Does pasteurization inactivate bird flu virus in milk?
Data provide direct evidence that the standard pasteurization methods used by dairy companies are effective in inactivating all tested subtypes of influenza viruses in raw milk.
Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63°C and 72°C
Findings highlight the need for research on HPAI A(H5N1) virus in dairy production.
Potential pandemic risk of circulating swine H1N2 influenza viruses
Influenza A viruses in swine have considerable genetic diversity and continue to pose a pandemic threat to humans due to a potential lack of population level immunity.
Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control
Avian influenza virus continues to pose zoonotic, epizootic, and pandemic threats worldwide, as exemplified by the 2020–23 epizootics of re-emerging H5 genotype avian influenza viruses
Cow’s Milk Containing Avian Influenza A(H5N1) Virus — Heat Inactivation and Infectivity in Mice
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal.
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Nirsevimab has been recently licensed for universal RSV prophylaxis in infants. NIRSE-GAL is a three-year population-based study initiated in Galicia in September 2023.
Article
Scientific Papers
Influenza H5N1 and H1N1 viruses remain infectious in unpasteurized milk on milking machinery surfaces
Article
News
Scientific Papers
US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses
